12:00 AM
 | 
Apr 20, 2009
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Nitec, Merck KGaA sales and marketing update

Merck launched Lodotra modified-release prednisone in Germany to treat rheumatoid arthritis (RA) and associated morning stiffness....

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >